Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Eye workouts may steady Parkinson's patients

NCT ID NCT07525973

Symptom relief Sponsor: Pardis Specialized Wellness Institute Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Sep 16, 2026 · Updated 5 times

Summary

This study tests whether a program of supervised eye exercises can improve physical function, balance, and reduce fear of falling in people with Parkinson's disease. 34 participants will do progressive eye movements and gaze stabilization exercises in a clinic setting. The goal is to see if these simple exercises can help with mobility and daily life.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
supervised in-center eye exercises
What this could lead to
If successful, this could offer a simple, non-drug way to improve balance and reduce fall risk for people with Parkinson's disease.
What could go wrong
This is a small, early-stage trial with only 34 participants, so results may not apply to everyone. The exercises are behavioral, so benefits may be modest and require ongoing practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 68 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2026

Expected to finish

Oct 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18-80 years with clinically diagnosed idiopathic Parkinson's disease; * Hoehn and Yahr stage 1-3; * Stable antiparkinsonian medication regimen for at least 4 weeks before enrollment; * Able to stand unaided and walk independently with or without an assistive device; * Adequate corrected vision to perform eye-exercise tasks; * Able to understand and follow simple exercise instructions; * Able to attend supervised in-center sessions three times per week for 8 weeks; * Able to provide written informed consent. Exclusion Criteria: * Unstable cardiovascular, orthopedic, vestibular, or neurological condition interfering with safe participation; * Active infection or acute medical illness; * Severe uncorrected visual impairment preventing participation in eye-exercise tasks; * Recent myocardial infarction or stroke within the past 3 months; * Change in antiparkinsonian medication during the 4 weeks before enrollment or planned medication change during the intervention period; * Severe dizziness, uncontrolled vertigo, or other condition that may be worsened by eye-head coordination exercises; * Any other condition judged by the study physician to make participation unsafe.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Parkinson disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Parkinson disease

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Pardis specialized wellness institute

    Isfahan, Iran

More trials for these conditions

Other studies related to the condition(s) this trial covers.